drugset / Trial / NCT01139450

Study of 0417 Ointment in the Treatment of Atopic Dermatitis

NCT01139450

Phase 3 Completed 899 enrolled Fougera Pharmaceuticals Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this trial is to assess the efficacy of 0417 Ointment in the Treatment of Atopic Dermatitis. Treatment medication will be administered as follows: Apply a thin layer of ointment to affected skin areas twice daily and rub in gently and completely. Study medication will be applied twice a day, approximately 12 hours apart, for approximately 4 weeks.

Timeline

Start
2008-01
Primary completion
2009-08
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject 0417 Unknown Topical
Comparator Tacrolimus Small molecule 0.03 % Topical

Indications